Business Segments Eisai Co., Ltd.

Equities

4523

JP3160400002

Pharmaceuticals

Delayed Japan Exchange Other stock markets 07:02:33 08/06/2026 am IST			5-day change	1st Jan Change
3,823.00 ^JPY	+1.27%		+0.37%	-17.98%

04/06	Eisai Co., Ltd. Announces Issuance of Unsecured Straight Bonds	CI
28/05	Jefferies Adjusts Eisai's Price Target to 4,000 Yen From 5,000 Yen, Keeps at Hold	MT

Sales 2025 by Business Segment

Sales 2025 by Geography

Historical Breakdown of Revenue by Business Segments

Operating Income: Breakdown by Business Segment

Breakdown by Business Segment (JPY)

Fiscal Period: March	2021	2022	2023	2024	2025
Pharmaceutical Products
Pharmaceutical Business - Americas	14TCr	17TCr	21TCr	23TCr	28TCr
Operating Income	6.47TCr	7.92TCr	13TCr	15TCr	16TCr
Pharmaceutical Business - Japan (Including Pharmaceutical Business - OTC and Others)	-	-	-	22TCr	22TCr
Operating Income	-	-	-	7.28TCr	7.17TCr
Pharmaceutical Business - China	8.51TCr	11TCr	11TCr	11TCr	12TCr
Operating Income	4.04TCr	5.54TCr	5.56TCr	5.77TCr	5.72TCr
Pharmaceutical Business - EMEA	5.52TCr	5.93TCr	7.22TCr	7.6TCr	7.94TCr
Operating Income	2.57TCr	4.09TCr	4.16TCr	4.2TCr	3.59TCr
Pharmaceutical Business - East Asia Global South	4.59TCr	5.06TCr	4.98TCr	5.42TCr	5.96TCr
Operating Income	1.86TCr	2.08TCr	2.21TCr	2.4TCr	2.74TCr
Pharmaceutical Business - Japan (Excl. Pharmaceutical Business - OTC Drugs)	23TCr	21TCr	22TCr	-	-
Operating Income	8.39TCr	6.12TCr	6.78TCr	-	-
Pharmaceutical Business - OTC and Others	2.52TCr	2.38TCr	2.35TCr	-	-
Operating Income	507.5Cr	470.2Cr	510.6Cr	-	-
Pharmaceutical Business - Japan (Including Consumer Healthcare Business - Japan)	-	-	-	-	-
Operating Income	-	-	-	-	-
Pharmaceutical Business - Asia	-	-	-	-	-
Operating Income	-	-	-	-	-
Pharmaceutical Business - Japan Pharmaceutical Business	-	-	-	-	-
Operating Income	-	-	-	-	-
CAPEX	-	-	-	-	-
Medicinal Chemicals and Botanical Products
Other Business	5.99TCr	13TCr	6TCr	5.03TCr	4.04TCr
CAPEX	-	-	-	-	-
Operating Income	5.15TCr	12TCr	4.85TCr	4.02TCr	2.96TCr
Vitamins and Nutritional Supplements
Pharmaceutical Business - CHB (Consumer Healthcare Business) Japan	-	-	-	-	-
Operating Income	-	-	-	-	-
Operating Income	-15TCr	-17TCr	-17TCr	-17TCr	-15TCr
Operating Income	-8.78TCr	-16TCr	-16TCr	-16TCr	-18TCr
Operating Income	-	-	-	-	-

Geographical Revenue Distribution History

Geographical breakdown of sales (JPY)

Fiscal Period: March	2021	2022	2023	2024	2025
United States (U.S.)	16TCr	17TCr	23TCr	24TCr	27TCr
Total Assets	22TCr	24TCr	25TCr	28TCr	27TCr
Japan	26TCr	24TCr	25TCr	23TCr	23TCr
Total Assets	19TCr	18TCr	17TCr	17TCr	16TCr
China	8.49TCr	11TCr	11TCr	11TCr	13TCr
Total Assets	1.75TCr	1.74TCr	1.6TCr	1.61TCr	1.47TCr
Europe	8.76TCr	13TCr	8.6TCr	9.05TCr	7.43TCr
Total Assets	1.53TCr	1.63TCr	1.68TCr	1.93TCr	1.95TCr
Others	4.95TCr	5.28TCr	6.02TCr	6.17TCr	7.23TCr
Total Assets	679.2Cr	701.4Cr	718.7Cr	809.3Cr	799.5Cr
Americas (Excluding United States)	278.7Cr	5.42TCr	793.7Cr	1.06TCr	1.36TCr
Total Assets	17Cr	17Cr	15Cr	39Cr	37Cr